14.07.2016 • NewsElaine BurridgeCrodaCroda International

Croda Buys Inventiva Technology Portfolio

(c) AVAVA/Shutterstock
(c) AVAVA/Shutterstock

Croda International has acquired the encapsulation and delivery system technology portfolio of Brazil’s Inventiva for an undisclosed sum. The Brazilian company was founded in 2008 by two entrepreneurs – Renata Raffin and Candice Felippi – with the aim of developing and manufacturing encapsulated systems mainly for the personal care industry. Raffin said Croda’s investment means that Inventiva will be able to focus on developing products for new application areas.

Both of the founders will become employees of subsidiary Croda Brazil. UK-based Croda said the acquisition, with which it will acquire strong customer relationships in Brazil and South America, along with good scientific data and leading knowledge, will form the basis of a research and technology platform for its products as well as other potential opportunities.

Marco Carmini, managing director of Croda Latin America, said Inventiva’s capabilities will allow it to expand its personal care offering in the short term and develop new and exciting ingredients for this and other market sectors in future. He added that the technologies meet the demands of niche, rapid growth markets, a strategic focus for the British company.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.